Your Evolution Has Begun
WHERE SCIENCE
MEETS LONGEVITY
Anera is a clinically driven longevity company built at the intersection of regenerative medicine, nanotechnology, and biologically intelligent health systems — designed to extend both the quality and duration of human life.
Discover Our Mission
WHY ANERA EXISTS
Truc Tran
Founder/Ceo
For decades, the healthcare industry has operated on a model built around disease management rather than genuine restoration. Patients were handed prescriptions designed to suppress symptoms, while the underlying biological dysfunction — the root cause of accelerated aging and chronic illness — was left entirely unaddressed. The founder of Anera witnessed this gap firsthand: brilliant clinicians constrained by systems that rewarded treatment over transformation.
The Journey
The path to founding Anera was not a straight line. It began in clinical practice, moved through years of independent research in regenerative science, and eventually converged with a team of pioneering scientists whose work in nanometallic therapeutics, epigenetics, and mitochondrial health pointed toward something genuinely new. The question was no longer "how do we treat disease?" — it became "how do we build a body that resists it?"
The Mission Behind Anera
Anera was founded on a singular conviction: that human beings deserve a healthcare system as sophisticated as the biology it serves. By uniting clinical expertise with cutting-edge longevity science, Anera is building protocols, products, and platforms that don't just extend lifespan — they elevate healthspan. Every decision the company makes is anchored in peer-reviewed science, clinical validation, and a deep respect for the complexity of human biology.
What Makes It Different
Unlike wellness brands that borrow the language of science without its rigor, Anera operates at the frontier. With 90+ patents in nanometallic silver oxide technology, a Scientific Advisory Board spanning integrative medicine, biological dentistry, and AI-driven analytics, and a clinical framework rooted in regenerative therapeutics, Anera represents a fundamentally different category — one where innovation is not a marketing claim, but a measurable outcome.
MISSION, VISION & SCIENTIFIC APPROACH
Our Mission
To advance human health by delivering clinically validated, biologically intelligent solutions that address the root causes of aging and disease — empowering individuals to live longer, healthier, and more vibrant lives through the convergence of regenerative medicine and precision science.
- Longevity science
- Regenerative medicine
- Biologically intelligent health systems
- Clinical innovation
Our Vision
A world in which biological aging is no longer an inevitable decline, but a manageable, measurable process — one that every person has the tools to influence. Anera envisions a global standard of care where regenerative science is accessible, evidence-based, and integrated into every stage of life.
Our Scientific Approach
Every Anera protocol is grounded in peer-reviewed research and guided by a multidisciplinary Scientific Advisory Board. Our approach integrates epigenetics, mitochondrial optimization, microbiome science, nanometallic therapeutics, and AI-driven longevity analytics into a unified clinical framework — built to deliver measurable biological outcomes.
GUIDED BY PIONEERING SCIENCE
Dr. Andrew Willoughby
President & Chief Science Officer
Dr. Andrew Willoughby is one of the most decorated scientists working at the intersection of nanotechnology and regenerative medicine today. As President and Chief Science Officer of Anera, he brings over three decades of research experience and a portfolio of more than 90 patents that have reshaped how clinicians and researchers think about nanometallic silver oxide technology and its therapeutic applications.
His pioneering work in nanometallic silver oxide research has established entirely new paradigms for antimicrobial and regenerative therapeutics — work that has been validated in clinical settings and recognized by leading scientific institutions worldwide. Dr. Willoughby's research has demonstrated that nanometallic compounds, when properly formulated and delivered, can interact with biological systems at the cellular level to promote healing, reduce inflammation, and support tissue regeneration.
Beyond the laboratory, Dr. Willoughby has been featured in PBS Medical Innovations, bringing his research to broader audiences and advocating for the integration of advanced nanotechnology into mainstream clinical practice. His ability to translate complex science into accessible, actionable protocols has made him a trusted voice in both the scientific community and the public health space.
At Anera, Dr. Willoughby leads the company's scientific strategy, overseeing all research and development initiatives, clinical trial design, and the ongoing expansion of Anera's proprietary technology platform. His vision is to build a science infrastructure that is not only innovative, but reproducible, transparent, and clinically meaningful.
THE MINDS BEHIND THE SCIENCE
Anera's Scientific Advisory Board brings together world-class clinicians, researchers, and innovators whose collective expertise guides the company's research direction, clinical strategy, and product development.
Manuel Riegner
Integrative & Longevity Medicine
A leading practitioner in integrative and longevity medicine, Manuel Riegner brings a systems-based approach to patient care that bridges conventional diagnostics with advanced regenerative protocols focused on optimizing biological age and extending healthspan.
Dr. Dean Raffelock
Clinical Nutrition & Formulation
A recognized authority in clinical nutrition and nutraceutical formulation, with decades of experience developing evidence-based supplementation protocols. His expertise in micronutrient science and metabolic optimization directly informs Anera's product formulation strategy.
Dr. Keith Moeller
Nano-Metallic Silver Technology
A globally recognized pioneer in nano-metallic silver technology, with an extensive publication and patent record in the field. His foundational research into the antimicrobial and regenerative properties of silver nanoparticles forms a cornerstone of Anera's proprietary therapeutic platform.
Dr. Scott Chandler
Biological Dentistry
A leading voice in biological dentistry, championing the critical connection between oral health and systemic wellness. His clinical practice and research focus on biocompatible dental materials, detoxification protocols, and the role of oral microbiome health in overall longevity.
Dr. Brad Labrecque
Nanotechnology Innovation
An innovator in applied nanotechnology with a focus on translating laboratory breakthroughs into clinically viable therapeutics. His work in nanoparticle delivery systems and bioavailability enhancement plays a key role in advancing Anera's next-generation product pipeline.
Dr. Craig Young
Oral-Systemic Health
A specialist in the emerging field of oral-systemic health, exploring the bidirectional relationship between the oral cavity and the body's broader physiological systems. His research highlights how oral inflammation and microbial imbalance can drive systemic disease.
Dr. Paul Sidhu
Longevity Medicine
A clinician and researcher dedicated to the science of longevity medicine, with a particular focus on hormonal optimization, cellular senescence, and the integration of wearable health data into personalized longevity protocols.
Dr. Kevin Mudrow
Biomimetic Dentistry
A specialist in biomimetic dentistry — a discipline focused on restoring teeth to their natural form, function, and aesthetics using materials and techniques that mimic natural tooth structure. His work informs Anera's oral health innovation strategy.
Dr. Gregory Eckel
Integrative Medicine
A practitioner and thought leader in integrative medicine, combining the best of conventional and complementary approaches to support whole-person health. His clinical philosophy — that the body has an innate capacity for healing when given the right conditions — aligns closely with Anera's core mission.
Advisor — Dr. Gabriel Alizaidy
Scientific Advisory Board
Anera continues to expand its Scientific Advisory Board with world-class experts advancing the frontiers of longevity science, regenerative medicine, and clinical innovation. An announcement is forthcoming.
THE PILLARS OF OUR RESEARCH
Anera's research and clinical strategy is organized around five core scientific pillars, each representing a frontier where the science of aging intersects with the possibility of meaningful biological intervention.
Epigenetics
Understanding how environmental signals, lifestyle factors, and targeted interventions can modify gene expression — without altering the underlying DNA sequence — to slow biological aging and promote cellular resilience.
Mitochondrial Health
Optimizing the function of the cell's energy-producing organelles to combat the mitochondrial dysfunction that underlies many age-related diseases, cognitive decline, and metabolic disorders — restoring cellular vitality at its source.
Microbiome Science
Mapping and modulating the complex ecosystem of microorganisms that inhabit the human body — particularly the gut-brain axis — to reduce systemic inflammation, improve immune function, and support the biological conditions for longevity.
Nanometallic Therapies
Leveraging the unique biological properties of nanometallic silver oxide compounds — backed by 90+ patents — to develop next-generation antimicrobial, anti-inflammatory, and regenerative therapeutics that operate at the cellular and subcellular level.
AI-Driven Longevity Analytics
Deploying artificial intelligence and machine learning to analyze complex biological datasets — from genomics and proteomics to wearable sensor data — enabling personalized longevity protocols that adapt in real time to each individual's unique biological profile.